BOC Sciences is a company focused on R&D and providing high-quality scientific compounds and services. When the new crown epidemic is raging, BOC Sciences is committed to helping prevent and control the epidemic, providing COVID-19 capabilities and COVID-19 testing services for relevant research institutions, medical institutions, pharmaceutical companies and individuals.
Since 2020, the COVID-19 virus has been wreaking havoc around the world, and in less than a year, this virus has hit almost every country and region in the world, causing a great impact. Faced with this challenge, countries around the world took various measures, including blocking cities, closing borders, and imposing social quarantines, to deal with the spread of the epidemic. With the introduction of a vaccine, the epidemic has been somewhat mitigated in some countries, but infection in other regions remains complex and uncertain. the long-term and global nature of the COVID-19 epidemic has given this event an unprecedented and far-reaching impact, causing people to rethink how we think about health and public health, and leading to many breakthroughs in science, technology and medicine in a short period of time.
Effective virus testing is critical to maintaining public health and safety. Since the first reported case of COVID-19, testing has been one of the most important strategies to control the spread of the virus.
A vaccine is one of the most important tools to prevent the spread of COVID-19. Scientists and physicians are urgently developing a vaccine for COVID-19 worldwide, which requires extensive research and testing support. By analyzing the genomic composition of the virus and studying appropriate vaccines and drugs, scientists have promoted different vaccines and are testing the efficacy and safety of these vaccines through a variety of methods.
Epidemiological studies of COVID-19 can provide a better understanding of how the virus is transmitted.
The development of innovative technologies is an important aspect of progress in COVID-19 research and testing support.
BOC Sciences offers a highly accurate, sensitive and speedy strategy for the determination of COVID-19. The strategy uses medical-surgical grade RT-qPCR technology to detect RNA from SARS-CoV-2 virus. BOC Sciences' laboratory facilities are equipped with advanced and efficient virus detection equipment and assay tools for the detection of viruses in samples. BOC Sciences' COVID-19 assay service is available for many different sample types, such as whole blood, serum, saliva, upper respiratory specimens and oropharyngeal swabs.
BOC Sciences provides COVID-19 viral capsid proteins S1 and S2 isolation, SARS-CoV-2 vaccine study, SARS-CoV-2 N520K variant detection, COVID-19 rapid antigen detection and peptide synthesis (SARS-CoV-2 Neutralizing Antibody), and other COVID-19 capability support services. All these services can help researchers and physicians to better understand the nature and development pattern of the new crown virus and better respond to the challenges of the new crown epidemic and disease.
Customers can choose the appropriate service according to their needs and requirements and communicate and consult with BOC Sciences' scientific team.